Lite Strategy Posts $71.2M Loss as Litecoin Holdings Sink 58% Below Cost
LITS sits 97% above its 52-week low of $0.689 on elevated volume (2.4× avg).
Summary
Lite Strategy's first full year as a Litecoin treasury company produced a $71.2 million net loss, driven by a $54.4 million non-cash hit from its digital asset holdings, which are now worth less than half their purchase price.
Key Events · Earnings and Guidance · LITS
-
Net Loss of $71.2 Million
Fiscal 2026 net loss of $71.2 million, up from $15.9 million in fiscal 2025, driven primarily by a $54.4 million non-cash loss from the change in fair value of digital assets.
-
Litecoin Holdings Deep Underwater
Company holds 832,716 LTC tokens with a fair value of $34.9 million against a cost basis of $82.4 million, representing a 58% unrealized loss.
-
Aggressive Share Repurchases
Repurchased 4,378,525 shares at $1.12 average price during fiscal 2026, plus an additional 1,999,604 shares between July 1 and September 22, 2026, with $20.2 million remaining under the $25 million program.
-
Auditor Change
Audit committee approved change from Deloitte & Touche LLP to CBIZ CPAs PC effective December 2, 2025.
Analysis · LITS · Life Sciences
The company's pivot to a Litecoin treasury strategy has backfired badly in its first year. The $54.4 million non-cash loss from digital asset remeasurement dwarfs the $12.2 million in total operating expenses, and the company's 832,716 LTC tokens are now worth $34.9 million against an $82.4 million cost basis. Management states cash and digital assets are sufficient for at least 12 months, but the company is simultaneously repurchasing shares while sitting on a massive unrealized loss, and the auditor change from Deloitte to CBIZ adds a governance question mark. The subsequent issuance of nearly 1.9 million additional warrants in July 2026 further dilutes existing holders.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LITS was trading at $1.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $46.3M. The 52-week trading range was $0.69 to $2.97. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.